Stocks and Investing Stocks and Investing
Fri, January 4, 2019
[ 12:00 AM ] - WOPRAI
Alexander Blostein Upgraded (ARES) to Strong Buy and Held Target at $23 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Matthew Harrison Initiated (ARGX) at Buy and Held Target at $140 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
David Leiker Downgraded (ADNT) to Sell and Decreased Target to $14 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Mitch Steves Downgraded (ADI) to Hold on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Steve Beuchaw Maintained (ALGN) at Hold with Decreased Target to $210 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Alexander Blostein Upgraded (CBOE) to Strong Buy and Held Target at $120 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (BX) at Buy with Decreased Target to $36 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Andrew Wittmann Maintained (UNF) at Buy with Decreased Target to $152 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Scott Gruber Maintained (WHD) at Strong Buy with Decreased Target to $41 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Scott Schrier Maintained (WMS) at Hold with Decreased Target to $27 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (BLK) at Buy with Decreased Target to $489 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Alexander Blostein Downgraded (TROW) to Hold and Held Target at $93 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (TROW) at Hold with Decreased Target to $98 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Vivek Arya Downgraded (TXN) to Hold on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Anthony Pettinari Maintained (SUM) at Strong Buy with Decreased Target to $18 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
John Lovallo Upgraded (AWI) to Strong Buy and Held Target at $75 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Kristen Stewart Downgraded (AVNS) to Sell and Decreased Target to $36 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Christopher Growe Maintained (SMPL) at Strong Buy with Increased Target to $22 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Heath Terry Downgraded (SNAP) to Hold and Decreased Target to $6 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Jack Atkins Upgraded (SNDR) to Buy on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Maintained (VRTX) at Strong Buy with Decreased Target to $205 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Michael Higgins Upgraded (VIRT) to Strong Buy and Held Target at $29 on, Jan 4th, 2019
[ 12:00 AM ] - WOPRAI
Scott Schrier Maintained (VMC) at Strong Buy with Decreased Target to $120 on, Jan 4th, 2019
Thu, January 3, 2019
[ 12:00 AM ] - WOPRAI
Seldon Clarke Initiated (VMC) at Strong Buy and Held Target at $116 on, Jan 3rd, 2019
[ 12:00 AM ] - WOPRAI
Derik De Bruin Upgraded (WAT) to Hold on, Jan 3rd, 2019
[ 12:00 AM ] - WOPRAI
David Unger Initiated (WAT) at Hold and Held Target at $177 on, Jan 3rd, 2019
[ 12:00 AM ] - WOPRAI
Vincent Caintic Upgraded (SYF) to Hold on, Jan 3rd, 2019
[ 12:00 AM ] - WOPRAI
Pito Chickering Initiated (SYK) at Strong Buy and Held Target at $179 on, Jan 3rd, 2019
[ 12:00 AM ] - WOPRAI
Kai Pan Maintained (TRV) at Sell with Decreased Target to $119 on, Jan 3rd, 2019
[ 12:00 AM ] - WOPRAI
Jack Meehan Upgraded (BIO) to Buy and Held Target at $315 on, Jan 3rd, 2019

Jack Meehan Upgraded (BIO) to Buy and Held Target at $315 on, Jan 3rd, 2019


Published on 2024-10-26 11:30:28 - WOPRAI, Jack Meehan
  Print publication without navigation


Jack Meehan of Barclays, Upgraded "Bio-Rad Laboratories, Inc." (BIO) to Buy and Held Target at $315 on, Jan 3rd, 2019.

Jack has made no other calls on BIO in the last 4 months.



There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 1 agrees with Jack's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Steve Beuchaw of "Morgan Stanley" Initiated at Hold and Held Target at $335 on, Thursday, September 20th, 2018


This is the rating of the analyst that currently disagrees with Jack

  • Patrick Donnelly of "Goldman Sachs" Initiated at Strong Buy and Held Target at $350 on, Wednesday, October 17th, 2018
Contributing Sources